In 1990, the first successful instance of human gene therapy occurred when a four-year-old girl suffering from severe combined immunodeficiency, often described as bubble boy disease, received treatment under the supervision of William French Anderson. This clinical achievement cemented his reputation within the scientific community as the person most central to the development of modern gene therapy practices.
Academic Foundation
Born in 1936 in Tulsa, Oklahoma, Anderson displayed academic aptitude early, graduating from Tulsa Central High School in 1954. He attended Harvard College, graduating in 1958, and continued his studies at Trinity College, Cambridge, where he earned an M.A. before completing his medical degree at Harvard Medical School in 1963. During his formative years, he published research on subjects ranging from Roman numerals to the effects of irradiation on DNA.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Research at the National Institutes of Health
Following an internship at Boston’s Children’s Hospital, Anderson joined the National Institutes of Health in 1965 to work with Marshall Nirenberg. He contributed to the decipherment of the genetic code and, in 1967, began leading his own laboratory. His research agenda prioritized developing methods to correct genetic defects at the molecular level, ultimately producing over 400 research papers and five books during his career.
Advances in Protein Synthesis
In 1970, Anderson identified protein synthesis initiation factors in mammals using rabbit reticulocytes. He developed a cell-free protein synthesizing system that allowed for the isolation of human messenger RNA. By programming this system with mRNA from human reticulocytes, he produced globin proteins, proving that genetic information could be successfully expressed in a controlled environment.
Development of Retroviral Vectors
Seeking a clinical protocol for gene delivery, Anderson moved toward using retroviral vectors. Collaborating with Eli Gilboa, he created vectors capable of transporting gene packages into cells. The N2 vector, designed to carry a neomycin resistance gene, proved effective in mouse bone marrow studies. These findings paved the way for subsequent safety trials in non-human primates and his later work at the University of Southern California.
Fast facts
- Born: 1936, Tulsa, Oklahoma
- Citizenship: United States
- Education: Harvard College, Trinity College, Harvard Medical School
- Primary Field: Genetics
- Notable Recognition: King Faisal International Prize in Medicine (1994)
- Significant Achievement: Led the first successful gene therapy in 1990
Questions readers ask
What is William French Anderson best known for?
He is widely recognized as the father of gene therapy for his pioneering work in molecular biology and the 1990 clinical trial that successfully treated severe combined immunodeficiency.
Where did he conduct his professional career?
After working for many years at the National Institutes of Health, he held a professional position at the University of Southern California.
Achievements
- King Faisal International Prize in Medicine — 1994
- Held posts at University of Southern California
- Fields: genetics
